CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma
Author:
Publisher
Informa UK Limited
Subject
Pharmacology,Molecular Medicine
Reference53 articles.
1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2. Genetic heterogeneity of diffuse large B-cell lymphoma
3. Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
4. The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma
5. International Non-Hodgkin’s Lymphoma Prognostic Factors P. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329(14):987–994. doi:10.1056/NEJM199309303291402
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gene expression profiles associated with early relapse during first remission induction in canine multicentric high-grade B-cell lymphoma;Journal of Veterinary Medical Science;2024
2. Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma;Frontiers in Immunology;2023-12-12
3. Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle;Clinical and Translational Oncology;2023-10-03
4. Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era;Experimental Hematology;2023-06
5. CHN1 promotes epithelial–mesenchymal transition via the Akt/GSK-3β/Snail pathway in cervical carcinoma;Journal of Translational Medicine;2021-07-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3